179 related articles for article (PubMed ID: 26908057)
1. A Model to Predict the Risk of Keratinocyte Carcinomas.
Whiteman DC; Thompson BS; Thrift AP; Hughes MC; Muranushi C; Neale RE; Green AC; Olsen CM;
J Invest Dermatol; 2016 Jun; 136(6):1247-1254. PubMed ID: 26908057
[TBL] [Abstract][Full Text] [Related]
2. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
Dai H; Li WQ; Qureshi AA; Han J
J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
[TBL] [Abstract][Full Text] [Related]
3. The incidence and multiplicity rates of keratinocyte cancers in Australia.
Pandeya N; Olsen CM; Whiteman DC
Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
[TBL] [Abstract][Full Text] [Related]
4. Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma.
Dusingize JC; Olsen CM; Pandeya NP; Subramaniam P; Thompson BS; Neale RE; Green AC; Whiteman DC;
J Invest Dermatol; 2017 Aug; 137(8):1700-1708. PubMed ID: 28414022
[TBL] [Abstract][Full Text] [Related]
5. Skin color parameters and Fitzpatrick phototypes in estimating the risk of skin cancer: A case-control study in the Polish population.
Sitek A; Rosset I; Żądzińska E; Kasielska-Trojan A; Neskoromna-Jędrzejczak A; Antoszewski B
J Am Acad Dermatol; 2016 Apr; 74(4):716-23. PubMed ID: 26777103
[TBL] [Abstract][Full Text] [Related]
6. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
7. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship.
Wilson A; Small J; Flanagan C; Perry D; Marchell R; Thiers B; Alberg AJ
Anticancer Res; 2019 Sep; 39(9):5083-5087. PubMed ID: 31519619
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations.
Cameron MC; Lee E; Hibler BP; Barker CA; Mori S; Cordova M; Nehal KS; Rossi AM
J Am Acad Dermatol; 2019 Feb; 80(2):303-317. PubMed ID: 29782900
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with the number of lesions excised for each skin cancer: a study of primary care physicians in Queensland, Australia.
Baade PD; Youl PH; Janda M; Whiteman DC; Del Mar CB; Aitken JF
Arch Dermatol; 2008 Nov; 144(11):1468-76. PubMed ID: 19015421
[TBL] [Abstract][Full Text] [Related]
11. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice.
Youl PH; Janda M; Aitken JF; Del Mar CB; Whiteman DC; Baade PD
Br J Dermatol; 2011 Jul; 165(1):35-43. PubMed ID: 21443534
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.
Claeson M; Pandeya N; Dusingize JC; Thompson BS; Green AC; Neale RE; Olsen CM; Whiteman DC
JAMA Dermatol; 2020 Dec; 156(12):1324-1332. PubMed ID: 33026421
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
[TBL] [Abstract][Full Text] [Related]
14. Algorithms for ascertaining keratinocyte carcinomas using health insurance claims and prescription records.
Zhang T; Lee TK; Lui H; Kunimoto B; Han C; Zhou Y; Kalia S
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):e275-e276. PubMed ID: 30762901
[No Abstract] [Full Text] [Related]
15. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
16. Trends in Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) in Canada: A Descriptive Analysis of Available Data.
Abbas M; Kalia S
J Cutan Med Surg; 2016; 20(2):166-75. PubMed ID: 26458408
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia.
Ramsay HM; Fryer AA; Hawley CM; Smith AG; Nicol DL; Harden PN
J Am Acad Dermatol; 2003 Sep; 49(3):397-406. PubMed ID: 12963901
[TBL] [Abstract][Full Text] [Related]
18. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
[TBL] [Abstract][Full Text] [Related]
19. Forearm hair density and risk of keratinocyte cancers in Australian adults.
von Schuckmann LA; Hughes MC; Green AC; van der Pols JC
Arch Dermatol Res; 2016 Nov; 308(9):617-624. PubMed ID: 27590883
[TBL] [Abstract][Full Text] [Related]
20. Sex hormones and the risk of keratinocyte cancers among women in the United States: A population-based case-control study.
Kuklinski LF; Zens MS; Perry AE; Gossai A; Nelson HH; Karagas MR
Int J Cancer; 2016 Jul; 139(2):300-9. PubMed ID: 26941014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
